Summit Therapeutics (SMMT) Tops Q3 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 16.17 +0.37 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.80 | 52 Week High | $19.75 | |||
| Open | $16.15 | 52 Week Low | $4.26 | |||
| Day High | $16.43 | P/E | N/A | |||
| Day Low | $15.41 | EPS | $0.00 | |||
| Volume | 4,257,609 | |||||
